Kidney Cancer research hub

International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors

This study, called i-RECORD, is looking at the best ways to treat kidney cancer around the world. It compares different treatments like surgery, burning off tumours, or just watching them closely. The aim is to understand which treatments work best for different people and improve future care.

Investigation of Differential Biology of Benign and Malignant Renal Masses Using Advanced Magnetic Resonance Imaging Techniques

This study uses new MRI scans to tell the difference between harmless and cancerous kidney growths. It aims to reduce unnecessary operations or tests for people with harmless growths by developing better ways to see inside the body.

Ex VIvo DEtermiNed Cancer Therapy

This study, called EVIDENT, wants to see if we can test a tiny piece of your tumour in the lab to predict how well cancer treatments will work for you. It's for people with various solid cancers, like bladder or kidney cancer, who are having surgery or a biopsy.

A Phase 2 BIOmarker driven trial with Nivolumab and Ipilimumab or VEGFR tKi in naïve metastatic Kidney cancer

This study is looking at new drug combinations (Nivolumab and Ipilimumab, or a VEGFR tKi) for kidney cancer that has spread. It aims to see how many people respond to the treatments and how long those responses last, hoping to find better ways to fight the cancer.

CA209-8KX Phase I/II pharmacokinetic multi-tumor study of subcutaneous formulation of nivolumab monotherapy